(PDF) P2.03-041 the Concentration of Avitinib in

P2.03-041 the Concentration of Avitinib in Cerebrospinal Fluid and Its Efficacy and Safety in NSCLC Patients With T790M Mutation

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2017.09.1292

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

November 1, 2017

Authors

Publisher

Elsevier BV

Related search

MA15.10 Loss of T790M Mutation Is Associated With Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-53 Comparison of the Treatment Efficacy of Osimertinib in Young and Elderly Patients With T790m-Positive NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-28 Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients With EGFR Mutation-Positive Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients With Alzheimer’s Disease

Journal of Alzheimer's Disease

Clinical Psychology

English

The Efficacy and Safety of Immunotherapy in Patients With Advanced NSCLC: A Systematic Review and Meta-Analysis

Scientific Reports

Multidisciplinary

English

P2.13-24 Prospective Efficacy of Osimertinib in Circulating Tumour DNA (ctDNA) T790m-Mutant NSCLC Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

Cerebrospinal Fluid and Its Physiology

Anaesthesia and Intensive Care Medicine

Intensive Care Medicine

English

Efficacy, Safety, and Resistance Profile of Osimertinib in T790M Mutation-Positive Non-Small Cell Lung Cancer in Real-World Practice

Multidisciplinary

English

Serum and Cerebrospinal Fluid S100B Concentrations in Patients With Neurocysticercosis

Brazilian Journal of Medical and Biological Research

English